IRCT20190831044653N5招募中2 期
Effect of atorvastatin on mortality rate and symptom improvement in hospitalized patients with COVID-19
Bojnourd University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •COVID-19 infected people who are inpatient in the hospital
排除标准
- •type 1 diabetes
- •ketoacidosis
- •Uncompensated heart failure
- •sever renal failure GFR<30ml/min
- •metabolic acidosis
- •structural respiratory dysfunction
- •Indications for Intubation at the registering time to the hospital
研究者
相似试验
招募中
3 期
Effectiveness of Atorvastatin on reducing of death and illness after catheterizatioIRCT20201028049175N10Arak University of Medical Sciences228
已完成
2 期
The effect of atorvastatin on patients with multiple sclerosisIRCT2015071323184N1Arak University of Medical Sciences60
已完成
2 期
Atorvastatin effect on ulcerative colitisIRCT20210713051878N1Islamic Azad University40
招募中
3 期
The effect of atorvastatin administration on the outcome of patients with traumatic brain injuryIRCT20210113050023N1Ahvaz University of Medical Sciences60
招募中
3 期
The effect of atorvastatin in the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapyIRCT20200825048515N36Esfahan University of Medical Sciences64